Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Ordinary Shares / American Depositary Shares
-
Shares outstanding
-
384M
-
Number of holders
-
15
-
Total 13F shares, excl. options
-
4.55M
-
Shares change
-
+1.88M
-
Total reported value, excl. options
-
$7.14M
-
Value change
-
+$3.02M
-
Number of buys
-
10
-
Number of sells
-
-7
-
Price
-
$1.57
Significant Holders of Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) as of Q3 2024
21 filings reported holding CMMB - Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares as of Q3 2024.
Chemomab Therapeutics Ltd. - Ordinary Shares / American Depositary Shares (CMMB) has 15 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.55M shares
of 384M outstanding shares and own 1.18% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (1.74M shares), SPHERA FUNDS MANAGEMENT LTD. (1.21M shares), Yelin Lapidot Holdings Management Ltd. (810K shares), MORGAN STANLEY (402K shares), Ikarian Capital, LLC (213K shares), TWO SIGMA SECURITIES, LLC (39.9K shares), KESTRA PRIVATE WEALTH SERVICES, LLC (31.2K shares), RHUMBLINE ADVISERS (27.6K shares), BOOTHBAY FUND MANAGEMENT, LLC (26.5K shares), and XTX Topco Ltd (15.2K shares).
This table shows the top 15 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.